• Estradiol-GPR30 Signaling Restores T Cell Function After Hem

  2026-08-04

  This study demonstrates that 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum stress, acting through ERα and GPR30 but not ERβ. The findings clarify receptor-specific mechanisms in post-trauma immune modulation and highlight the utility of selective G protein-coupled estrogen receptor antagonists in dissecting estrogen signaling.

• Superoxide Dismutase (SOD) Activity Assay Kit: Protocol & QC

  2026-08-04

  The Superoxide Dismutase (SOD) Activity Assay Kit enables precise, quantitative measurement of SOD enzyme activity in biological fluids, facilitating research on oxidative stress and antioxidative defense. It is well-suited for workflows requiring rapid, colorimetric detection of SOD activity, but should not be used for diagnostic or clinical applications.

• Y-27632 ROCK Inhibitor: Optimizing Organoid and Cytoskeletal

  2026-08-03

  Y-27632 is a benchmark tool for selective ROCK inhibition, enabling robust cytoskeletal modulation, stem cell survival, and organoid propagation. This guide translates the latest cancer organoid research and advanced cytoskeletal workflows into practical, data-driven strategies for researchers leveraging APExBIO’s trusted Y-27632.

• Alda 1: ALDH2 Activator Workflows for Cardiac and Radiation

  2026-08-03

  Alda 1 unlocks precise modulation of ALDH2 activity, driving advances in both cardiac ischemia and radiation-induced dermatitis models. This article delivers stepwise protocols, evidence-backed troubleshooting, and integration of new cardioprotective insights to help researchers maximize experiment yield.

• Protease Inhibitor Cocktail EDTA-Free: Safeguarding Pluripot

  2026-08-02

  Explore the pivotal role of Protease Inhibitor Cocktail EDTA-Free in protecting protein integrity during embryonic stem cell research. This article uniquely bridges advanced inhibitor technology with the latest breakthroughs in pluripotency and epigenetic regulation.

• L-Alanyl-L-Glutamine: Applied Workflows for Intestinal Barri

  2026-08-01

  L-Alanyl-L-Glutamine unlocks new possibilities in gastrointestinal research, elevating barrier protection and mucosal integrity under even the most challenging catabolic conditions. This article delivers actionable protocol guidance, troubleshooting tactics, and evidence-driven workflow enhancements to help researchers maximize the compound’s translational impact.

• Bacitracin (B1670): Technical Use and Protocol Parameters

  2026-07-31

  Bacitracin (B1670) is a peptide antibiotic designed for laboratory-based antibacterial research, specifically targeting bacterial cell wall and peptidoglycan synthesis. It should be used only in controlled research workflows and is not intended for diagnostic or medical applications.

• O-propargyl-puromycin (OPP): Protein Synthesis Detection in

  2026-07-31

  O-propargyl-puromycin (OPP) transforms protein synthesis measurement in living cells, providing unmatched specificity and workflow flexibility for immunology and proteomics research. This article details experimental setups, advanced applications, and troubleshooting, with practical guidance grounded in recent mechanistic studies of antibody-producing B cells.

• Nirmatrelvir (PF-07321332): Structural Insights and New Fron

  2026-07-30

  Explore the molecular basis and translational significance of Nirmatrelvir (PF-07321332) as a SARS-CoV-2 3CL protease inhibitor. This in-depth analysis reveals how structural understanding shapes novel antiviral therapeutics research and illuminates key experimental considerations.

• Sulfo-NHS-Biotin: Elevating Cell Surface Protein Labeling

  2026-07-30

  Sulfo-NHS-Biotin empowers selective, high-fidelity cell surface protein labeling with unmatched aqueous compatibility, as proven in advanced single-cell functional assays. This article breaks down applied workflows, troubleshooting strategies, and protocol optimizations to maximize reproducibility, drawing on both reference and peer-reviewed studies.

• Podophyllotoxin as a Precision Tool for Autophagy and Cell C

  2026-07-29

  Explore how Podophyllotoxin, a potent antineoplastic agent, serves as a precision instrument for dissecting autophagy and cell cycle arrest in cancer models. This article uniquely bridges mechanistic depth and translational assay strategy, offering new insight into optimizing research beyond established protocols.

• Tobramycin: Aminoglycoside Antibiotic Benchmarks & Applicati

  2026-07-29

  Tobramycin is a high-purity aminoglycoside antibiotic that inhibits bacterial protein synthesis and is essential for Gram-negative resistance research. Its spectrum, mechanistic benchmarks, and practical limitations are defined by rigorous in vitro evidence, making it a critical standard for microbiology workflows.

• Tomivosertib: Precision MNK1 Inhibitor Workflows in AML Rese

  2026-07-28

  Tomivosertib stands out as a highly selective MNK1 inhibitor, enabling researchers to dissect the MNK-eIF4E signaling pathway with exceptional specificity. Its robust inhibition of eIF4E phosphorylation supports advanced workflows in acute myeloid leukemia, neuronal, and metabolic models, with evidence-based protocol optimizations drawing from the latest translational studies.

• Mitochondrial Defects Drive AML Sensitivity to Mitocans

  2026-07-28

  The reference study systematically uncovers why acute myeloid leukemia (AML) cells are more sensitive to mitochondria-targeted anticancer agents than other tumor types. By linking unique mitochondrial metabolic defects in AML to heightened mitocan response, this work highlights mitochondrial function as a selective vulnerability in leukemia and guides future combinatorial therapy design.

• Temafloxacin: Fluoroquinolone Antibacterial Agent for Resear

  2026-07-27

  Temafloxacin empowers infection researchers with robust, reproducible workflows for both extracellular and intracellular pathogens. Explore detailed protocol parameters, advanced applications, and troubleshooting strategies that maximize the value of this fluoroquinolone broad-spectrum antibacterial agent.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page